Biopharma Cold Chain Logistics Market Share, Size, Trends, Industry Analysis Report, By Component (Storage [Warehouse, Refrigerated Container], Transportation [Sea Freight Logistics, Air Freight Logistics, Overland Logistics], Monitoring Components); By Regions; Segment Forecast, 2020 - 2027
- Published Date: Dec 2020
- Pages: 118
- 格式：PDF.
- Report ID: PM1766
- 基数：2019年
- 历史数据：2016 - 2018年
报告摘要
2019年全球生物生物野牛冷链物流市场价值为156亿美元，预计将在2020年至2027年期间复合7.1％的复合年增长率为7.1％。市场增长尤其受到温度敏感药物和生物制药产品的巨大需求所驱动的作为发达经济体的救生疫苗和血浆。在Covid-19大流行中，常规和反毒品的贸易从国家到国家增加。
For instance, the U.S. Food & Drug Administration (FDA), recently, has approved emergency use authorization (EUA) for the drug hydroxyl-chloroquine, mostly manufactured in India, to be used as an antibiotic for the patients suffering with COVID-19 symptoms. The biopharma logistics companies are focused on developing their supply chain models robust, in line with this, they are keeping an eye on latest technologies real time supply chain visibility, warehouse robotics, digital twins, blockchain and analytics, and autonomous vehicles.
了解有关此报告的更多信息：request for sample pages
有利于市场增长的其他因素包括对柜台（OTC）药物的需求增加，通过技术，成本遏制措施，以维持最佳分配和包装成本的成本遏制措施，以及投资的快速交付产品的重要性。远程信息处理和远程监控技术，以减少运输过程中的产品掺假病例。
行业动态
Growth Drivers
Pharma物流公司正在使用IoT，自治车辆等先进技术，blockchainto enhance operational efficiency. Blockchain maintains digital ledger to maintain, record, and authenticate data, while IoT comprises of set of physical devices for communication over the internet. This technology enables biopharma companies to reduce operational transportation costs, lead time, and real time monitoring of cargo. It achieves cost savings by automating error free processes, by streamlining distribution operations. For instance, global logistics service providers such as DHL and Accenture have developed serialization prototype with blockchain technology to track shipment across six geographies.
最近，在2020年9月，DHL全球转发，DHL集团的实体，宣布技术改善其生命科学服务部门，以满足不断变化的制药物流需求，以反对由于Covid-19大流行引起的破坏。它推出了“新的Lifetrack用户界面”，一个温度控制的装运跟踪门户，为其客户提供实时分析，数字化标准操作程序（SOP）信息和车道风险评估工具。这将使公司的LifeConex和ThermoNet客户端实时访问包装时间，提前期和产品向目标目的地提供。此外，基于丹麦的货运集装箱公司Maersk正在使用IoT使能的冷藏集装箱，以确保犯规，从掺假，错位和盗窃中的安全。Skycell提供了IOT启用的冷藏集装箱，专为制药产品设计。
Biopharma冷链物流市场报告范围
市场主要是在组成部分和地理区域的基础上进行细分。
由组件 |
按地区 |
|
|
了解有关此报告的更多信息：request for sample pages
组件洞察力
Based on components, the global biopharma cold chain logistics market is categorized into storage, transport, and component. In 2019, the storage segment accounted for the largest revenue share. The factors responsible for its growth include the surge in demand for temperature-sensitive nutritional supplements and temperature-sensitive vaccines. The adoption of sea-based pharma logistics, as sea freight is capable of handling personalized medicines, is also driving the segment growth.
地理概述
North America accounted for the largest revenue share in 2019. The growth in the regional market is attributed to the presence of major players operating in the concerned market. These players are involved in several strategic initiatives, which is taking the market forward. For instance, in August 2018, ICS, Texas-based pharma distribution services company, established its new third-party logistics and distribution center in Ohio. This 350,000 sq. ft. facility will strengthen the company’s robust distribution capabilities with embedded state of art technology.
Both the U.S. and Canada have a well-developed infrastructure of pharma logistics and distribution, and the players are focusing on newer technologies and investing in supply chain processes to minimize wastage and losses. According to the statistics published by the WHO and the Parenteral Drug Association (PDA), more than 25% of the transported vaccines incorrectly reach their target destination, 20% of the temperature-sensitive product were damaged due to temperature excursion, and the average cost for the root cause of damaged goods is USD 7 thousand.
亚太地区是按cted to be the fastest-growing region, owing to the rapid economic strides made by these emerging economies. The pharmaceutical industry is undergoing a rapid change, owing to a surge in demand for drugs and vaccines from the huge population base. This is paving the way for a pharma logistics firm to take advantage of being India as being the world’s pharmaceutical hub and China being the largest producer of raw materials APIs used in the pharma industry for generics and OTC drugs. It is being estimated that more than 60% of the raw material being used is procured from China alone.
竞争洞察力
Key players operating in the global biopharma cold chain logistics market include Air Canada, DB Schenker, Kuehne+ Nagel, Agility, Deutsche Post AG, United Parcel Service of America, Inc., Deutsche Post DHL, LifeConEx, VersaCold Logistics Services, Panalpina World Transport, Marken, FedEx, and CEVA Logistics.
